Acquisition of Services for cGMP Testing of PEN-866 Drug Conjugate
Posted Date:
Jul 14, 2025
Jul 18, 2025
Awarded Date:
No Awarded Date
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| 75N91025Q00045 | Acquisition of Services for cGMP Testing of PEN-866 Drug Conjugate | |
| Synopsis | ||
|
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Pediatric Oncology Branch (POB) plans to procure, on a sole source basis, for the generation of a new Certificate of Analysis (CoA) for the drug conjugate PEN-866 from: PPD Development LP (PPD) The response close date of the notice for this requirement is in accordance with FAR 5.203(b). This acquisition will be processed under FAR Part 12 – Acquisition for Commercial Items and will be made pursuant .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| NATIONAL INSTITUTES OF HEALTH | Presolicitation | |
